NDC 51662-1620-01 - NALOXONE HCl
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 51662-1620
- Requested NDC
- 51662-1620-01
- Package NDCs from labels
- 51662-1620-1, 51662-1620-2, 51662-1620-01
- Manufacturer
- HF Acquisition Co LLC, DBA HealthFirst
- Effective date
- 2024-01-28
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| NALOXONE HCl - HF Acquisition Co LLC, DBA HealthFirst | HF Acquisition Co LLC, DBA HealthFirst | 2024-01-28 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51662-1620-1 | NALOXONE HCl | 0.1 mL in 1 VIAL, SINGLE-DOSE | SPRAY | 0.1 | 2 | |
| 51662-1620-2 | NALOXONE HCl | 0.1 mL in 1 VIAL, SINGLE-DOSE | SPRAY | 0.1 | 2 | |
| 51662-1620-2 | NALOXONE HCl | 2 in 1 CARTON | SPRAY | 2 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 51662-1620 | NALOXONE HCL SPRAY [HF ACQUISITION CO LLC, DBA HEALTHFIRST] | 2 | Current NDC, 3 package rows | 20240130_f8fcda15-8ba6-e66a-e053-6294a90a385c.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Naloxone Hydrochloride | NALOXONE HYDROCHLORIDE | Mylan Institutional LLC | f0932877-1f3b-4d5e-82d2-dd6c53db4730 | 2020-08-17 | Warnings, Adverse reactions | F850569PQR |
| Naloxone Hydrochloride | NALXONE HYDROCHLORIDE | Hikma Pharmaceuticals USA Inc. | 8cc25cf1-008c-4808-baec-49f35a887fae | 2020-03-20 | Warnings, Adverse reactions | F850569PQR |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.